Frank V. Strona1, Jacqueline McCright
2, Stephen Tierney
3, Katherine Ahrens
2, Steven Gibson
4, C. Bradley Hare
5, Michael Siever
6, Jim Kahn
7, Steven Shoptaw
8, Cathy Reback
8, Jeff Dang
9, Bob Cabaj
10, John Stansell
5, Jeffrey D. Klausner
2, and William D. King
11. (1) STD Prevention & Control Services, San Francisco Department Of Public Health, 1360 Mission St, Suite 401, San Francisco, CA, USA, (2) STD Prevention and Control Services, San Francisco Department of Public Health, 1360 Mission St, Suite 401, San Francisco, CA, USA, (3) San Francisco AIDS Foundation, 995 Market Street, Suite 200, San Francisco, CA, USA, (4) Magnet, 4122 18th street, San Francisco, CA, (5) Ward 84, San Francisco General Hospital, 995 Potrero Avenue, UCSF Box 0881, San Francsico, CA, USA, (6) The Stonewall Project, San Francisco, CA, USA, (7) UCSF, Positive Health Practice, San Francisco, CA, USA, (8) Friends of Research Institute, Inc, 11075 Santa Monica Blvd. Suite 200, Los Angeles, CA, USA, (9) UCLA Integrated Substance Abuse Programs, UCLA, Los Angeles, CA, USA, (10) San Francisco Department of Public Health, San Francisco, CA, USA, (11) UCLA Department of Infectious Diseases, Los Angeles, CA
Background:
Methamphetamine use continues to be a growing problem among men who have sex with men (MSM) and is associated with increased rates of HIV and STDs.
Objective:
To use contingency management (positive reinforcement) in 200 MSM, currently using methamphetamine. To evaluate the treatment effect on drug use.
Method:
The pilot program was a collaboration between the San Francisco Department of Public Health (STD Prevention & Control Services, HIV Prevention Section, Behavioral Health), the Positive Health Program, Magnet, Continuum, UCLA Integrated Substance Abuse Programs and the Friends Research Institute, Inc.
Project recruitment was through street based contact and provider referrals, and clients could participate anonymously. PROP operated sites in two locations for 2 hours each, three times a week. PROP included a behavioral risk intake process and observed urine testing of participants Mondays, Wednesdays and Fridays for 12 weeks, offering increasing incentives for each negative methamphetamine test. Upon a positive methamphetamine test result, staff would encourage the participant to return and try again. If a participant remained negative for 36 visits, they could earn a total of $453.75. No other therapies or support were offered with the exception of a community referral guide.
Result:
211 men have participated in the initial intake process during December 1, 2004 – December 6, 2005. 162 (77%) of the men initiated treatment. Of 149 men eligible to complete, 90 (60.4 %) completed four weeks, 72 (48.3%) completed eight weeks, and 44 (29.5%) completed treatment (12 weeks).
Conclusion:
Contingency management is a feasible, low cost, minimally staffed strategy to reduce methamphetamine use in MSM. Further evaluation is currently being performed.
Implications:
PROP is potentially a low cost, culturally appropriate treatment option for those not motivated to seek other treatment methods.